147 related articles for article (PubMed ID: 7826981)
1. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
2. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors.
Hwang SL; Chai CY; Lin HJ; Howng SL
Kaohsiung J Med Sci; 1997 Jul; 13(7):417-24. PubMed ID: 9260461
[TBL] [Abstract][Full Text] [Related]
4. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
Kristt DA; Yarden Y
Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
[TBL] [Abstract][Full Text] [Related]
5. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
[TBL] [Abstract][Full Text] [Related]
7. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of epidermal growth factor receptor in human high-grade astrocytomas--a comparison between frozen- and paraffin sections.
Torp SH; Bringedal K; Dalen A
J Exp Clin Cancer Res; 2005 Mar; 24(1):89-92. PubMed ID: 15943037
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
Bodey B; Kaiser HE; Siegel SE
In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
[TBL] [Abstract][Full Text] [Related]
15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
16. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
Bian XW; Shi JQ; Liu FX
Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
[TBL] [Abstract][Full Text] [Related]
17. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.
Torp SH; Gulati S; Johannessen E; Dalen A
J Exp Clin Cancer Res; 2007 Sep; 26(3):353-9. PubMed ID: 17987795
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]